Engineered trivalent immunogen adjuvanted with a STING agonist confers protection against Trypanosoma cruzi infection
Chagas disease: protecting from chronic parasitic disease An amalgamation of parasitic proteins may be the first effective vaccine against the as yet untreatable chronic phase of Chagas disease. The infliction, caused by the parasite Trypanosoma cruzi (T. cruzi), is the world’s leading cause of infe...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2017-04-01
|
| Series: | npj Vaccines |
| Online Access: | https://doi.org/10.1038/s41541-017-0010-z |